May
27
  11:35:34 PM

The perils of ancestor testing

Genetic ancestry testing is a practice that has become increasingly popular in the US. An estimated half-million Americans will purchase a genetic ancestry test from one of the 40 companies around the world which offer them. However, professional geneticists are worried about the accuracy and personal and societal implications of this type of testing.

A task force for American Society of Human Genetics complains in a recent issue of its journal that “A major issue regarding commercial ancestry testing is that there is no quality assurance guarantee”. This is far more than a technical issue. For many people, their ancestry is a matter of deep personal concern. Government benefits are also available to people who can prove that they belong to a particular group. A focus on genetic distinctions can lead to the discredited notion of separate races. Some applications could cause “palpable threats to human welfare”. The whole area is so fraught that some US geneticists have called for government regulation.

The ASHG takes a more moderate stand and has recommended developing “mechanisms for promoting thoughtful and rigorous use of genetic ancestry estimation in academic research” and a national roundtable discussion of direct-to-consumer ancestry testing. “The time is now for no-holds-barred discussions among the players, particularly among scientists who must more purposefully and constructively critique one another’s premises, methodologies, findings, and interpretations of findings,” they say. ~ American Journal of Human Genetics, May 14



 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Neuroscience as the military’s new weapon
9 Feb 2012
Single-embryo transfers? Fugedaboudit, says NY IVF doctor
9 Feb 2012
Dutch celebrate a decade of euthanasia with a film festival
6 Feb 2012
Lost in surrogacy’s Bermuda Triangle
3 Feb 2012
Scores of UK patients die with bedsores, infections and malnutrition
3 Feb 2012

 Tags
euthanasia, UK, clinical trials, Canada, suicide, commercialization, law, China, HFEA, US, Australia, genetic testing, sperm donation, abortion, embryonic stem cells, Netherlands, organ donation, IVF, Down syndrome, informed consent, stem cells, sex selection, neuroscience, organ trafficking, surrogacy, India, assisted suicide, bioethics, research, human drama,